Bone loss after Weight-Loss surgery: could a simple pill help?
NCT ID NCT04922333
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a monthly pill called risedronate can reduce bone and muscle loss after sleeve gastrectomy, a common weight-loss surgery. About 200 adults who have had the surgery will take either risedronate or a placebo for 6 months and be followed for a year. The goal is to see if this FDA-approved osteoporosis drug can protect bone health in this specific situation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BONE LOSS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wake Forest School of Medicine
RECRUITINGWinston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A common supplement may shield bones in kidney disease — a trial puts it to the test
- Could a single abutment placement save your jawbone?
- Drilling speed showdown: which dental implant technique preserves bone better?
- Denture cap showdown: which material saves more bone?
- Bone-Saving drug may shield patients after bariatric surgery
- Massive UK study tracks 12,000 women and their children for 20 years to unlock secrets of lifelong health